X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18886) 18886
Newsletter (76) 76
Magazine Article (28) 28
Book Chapter (26) 26
Newspaper Article (18) 18
Dissertation (7) 7
Book / eBook (3) 3
Trade Publication Article (3) 3
Conference Proceeding (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (13067) 13067
seizures - chemically induced (12936) 12936
male (11397) 11397
rats (7502) 7502
humans (6876) 6876
seizures (5661) 5661
female (5331) 5331
epilepsy (4592) 4592
mice (4544) 4544
neurosciences (4466) 4466
clinical neurology (2942) 2942
seizures - physiopathology (2827) 2827
disease models, animal (2580) 2580
pharmacology & pharmacy (2522) 2522
seizures - drug therapy (2316) 2316
electroencephalography (2300) 2300
dose-response relationship, drug (2265) 2265
adult (2242) 2242
rats, sprague-dawley (2154) 2154
rats, wistar (2063) 2063
brain (1958) 1958
anticonvulsants - pharmacology (1745) 1745
anticonvulsants - therapeutic use (1705) 1705
time factors (1704) 1704
hippocampus (1700) 1700
pentylenetetrazole (1699) 1699
kainic acid (1642) 1642
seizures - metabolism (1635) 1635
seizures - prevention & control (1624) 1624
neurology (1620) 1620
seizure (1527) 1527
hippocampus - drug effects (1513) 1513
middle aged (1409) 1409
brain - drug effects (1387) 1387
status epilepticus (1366) 1366
brain - metabolism (1313) 1313
epilepsy - chemically induced (1244) 1244
analysis (1221) 1221
temporal-lobe epilepsy (1195) 1195
anticonvulsants (1151) 1151
status epilepticus - chemically induced (1140) 1140
behavior, animal - drug effects (1132) 1132
adolescent (1080) 1080
hippocampus - metabolism (1065) 1065
neurons (1047) 1047
pilocarpine (1038) 1038
rats, inbred strains (1028) 1028
anticonvulsants - adverse effects (1017) 1017
child (1013) 1013
rat (1013) 1013
psychiatry (950) 950
epilepsy - drug therapy (897) 897
hippocampus - pathology (895) 895
antiepileptic drugs (869) 869
cats (829) 829
gaba (821) 821
aged (811) 811
drug interactions (790) 790
toxicology (789) 789
child, preschool (781) 781
neurons - drug effects (781) 781
seizures - pathology (767) 767
epilepsy - physiopathology (757) 757
hippocampus - physiopathology (752) 752
infant (696) 696
glutamate (692) 692
motor activity - drug effects (691) 691
electroshock (660) 660
convulsions (644) 644
mice, inbred c57bl (642) 642
seizures - etiology (639) 639
pentylenetetrazole - pharmacology (625) 625
biochemistry & molecular biology (624) 624
cerebral cortex - drug effects (621) 621
behavioral sciences (611) 611
brain - physiopathology (609) 609
electroencephalography - drug effects (607) 607
anticonvulsant (601) 601
convulsants (587) 587
expression (579) 579
anticonvulsants - administration & dosage (567) 567
drugs (563) 563
treatment outcome (558) 558
pediatrics (544) 544
pregnancy (544) 544
neurons - metabolism (538) 538
kainic acid - toxicity (532) 532
convulsions & seizures (519) 519
electric stimulation (519) 519
brain - pathology (514) 514
immunohistochemistry (510) 510
rat-brain (510) 510
dentate gyrus (509) 509
induced seizures (505) 505
epileptogenesis (493) 493
rodents (489) 489
pentylenetetrazol (485) 485
risk factors (481) 481
in vitro techniques (479) 479
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17764) 17764
Russian (355) 355
French (250) 250
Japanese (243) 243
German (237) 237
Spanish (106) 106
Italian (89) 89
Chinese (63) 63
Polish (40) 40
Danish (22) 22
Dutch (21) 21
Norwegian (9) 9
Portuguese (9) 9
Romanian (9) 9
Bulgarian (8) 8
Hebrew (8) 8
Swedish (8) 8
Hungarian (4) 4
Croatian (3) 3
Czech (3) 3
Finnish (3) 3
Serbian (3) 3
Slovak (2) 2
Turkish (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of neurochemistry, ISSN 0022-3042, 2010, Volume 115, Issue 4, pp. 1035 - 1044
.... The aim of this study was to explore the effects of a pure Hsp70/Hsc70 preparation delivered to the brain regions involved in generalized seizures induced in rats by intracerebroventricular... 
synaptophysin | Hsp70 | rat | brain | GAD67 | chemically‐induced seizures | Chemically-induced seizures | Brain | Synaptophysin | Rat | BIOCHEMISTRY & MOLECULAR BIOLOGY | chemically-induced seizures | INDUCTION | NEUROSCIENCES | HEAT-SHOCK-PROTEIN | MOUSE MODEL | ANIMAL-MODELS | ANTIEPILEPTIC DRUGS | STRESS | EXPRESSION | AGGREGATION | Recombinant Proteins - therapeutic use | Prospective Studies | Seizures - prevention & control | Rats, Wistar | Humans | Male | Protein Transport - physiology | Seizures - metabolism | Protein Transport - drug effects | Seizures - chemically induced | Brain - metabolism | Seizures - physiopathology | Pentylenetetrazole - toxicity | Cattle | Severity of Illness Index | HSP70 Heat-Shock Proteins - therapeutic use | Brain - physiopathology | Anticonvulsants - metabolism | Anticonvulsants - therapeutic use | Rats | Recombinant Proteins - pharmacology | Brain - drug effects | Animals | HSC70 Heat-Shock Proteins - therapeutic use | HSP70 Heat-Shock Proteins - physiology | HSC70 Heat-Shock Proteins - physiology | N-Methylaspartate - toxicity | Enzymes | Methyl aspartate | Neurons | Epilepsy | Physiological aspects | Heat shock proteins | GABA | Glutamate decarboxylase | Seizures (Medicine) | Neurochemistry | Convulsions & seizures | Rodents | Shock | Neuroprotection | Immunoprecipitation | g-Aminobutyric acid | Glutamic acid receptors (ionotropic) | Central nervous system | N-Methyl-D-aspartic acid receptors | Hsp70 protein | Chaperones | Anticonvulsants | Microinjection | Pentylenetetrazole | Neurotransmission | Seizures
Journal Article
Neurobiology of disease, ISSN 0969-9961, 2014, Volume 65, pp. 133 - 141
Abstract Synchronized activity is common during various physiological operations but can culminate in seizures and consequently in epilepsy in pathological... 
Neurology | Mouse | GABA | NpHR | Epileptiform | Seizure | Optogenetics | Picrotoxin | Inhibition | Hippocampus | Bicuculline | Aminopyridines | Excitatory Amino Acid Agonists | Transduction, Genetic | GABA Agents | Neurons | Status Epilepticus | Journal Article | Bacterial Proteins | Kainic Acid | Action Potentials | Patch-Clamp Techniques | Animals | Analysis of Variance | Membrane Potentials | Research Support, Non-U.S. Gov't | Female | Mice | In Vitro Techniques | Halorhodopsins | Luminescent Proteins | Disease Models, Animal | GABA Antagonists | STIMULATION | TEMPORAL-LOBE EPILEPSY | GABA-MEDIATED INHIBITION | MODEL | INTERICTAL SPIKES | EPILEPTOGENESIS | NEUROSCIENCES | SEIZURES | EPILEPTIFORM ACTIVITY | IN-VIVO | Status Epilepticus - chemically induced | Neurons - physiology | Kainic Acid - toxicity | Neurons - drug effects | Action Potentials - drug effects | Membrane Potentials - drug effects | Bacterial Proteins - genetics | Membrane Potentials - physiology | GABA Antagonists - pharmacology | GABA Agents - pharmacology | Excitatory Amino Acid Agonists - toxicity | Halorhodopsins - metabolism | Halorhodopsins - genetics | Aminopyridines - pharmacology | Picrotoxin - pharmacology | Status Epilepticus - physiopathology | Bacterial Proteins - metabolism | Luminescent Proteins - genetics | Luminescent Proteins - metabolism | Epilepsy | Seizures (Medicine) | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
Epilepsia, ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Summary Many symptoms of neurologic or psychiatric illness—such as cognitive impairment, depression, anxiety, attention deficits, and migraine—occur more... 
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | DEPRESSIVE-LIKE BEHAVIOR | TEMPORAL-LOBE EPILEPSY | GENETIC ABSENCE EPILEPSY | ENVIRONMENTAL ENRICHMENT | KETOGENIC DIET | CLINICAL NEUROLOGY | TRAUMATIC BRAIN-INJURY | EARLY-LIFE SEIZURES | SPATIAL MEMORY | INDUCED STATUS EPILEPTICUS | IMMATURE RATS | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life
Journal Article
Journal Article
Journal Article
Journal of child psychology and psychiatry, ISSN 0021-9630, 2013, Volume 54, Issue 3, pp. 227 - 246
Background:  Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well‐tolerated, there are common,... 
ADHD | medication | adverse events | European | management | recommendations | SUBSTANCE USE DISORDERS | SLEEP | SUDDEN-DEATH | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | SERIOUS CARDIOVASCULAR EVENTS | FOLLOW-UP | DEFICIT-HYPERACTIVITY DISORDER | PSYCHOLOGY | STIMULANT MEDICATIONS | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | PEDIATRIC-PATIENTS | OROS METHYLPHENIDATE | Therapy | Behavior Disorders | Europe | Drug Therapy | Risk | Foreign Countries | Suicide | Substance Abuse | Patients | Scientific Research | Incidence | Guidelines | Physical Development | Outcomes of Treatment | Sleep | Attention Deficit Hyperactivity Disorder | Literature Reviews | Meta Analysis | Symptoms (Individual Disorders) | Eating Habits | Seizures | Sleep Wake Disorders - chemically induced | Tic Disorders - therapy | Cardiovascular Diseases - prevention & control | Humans | Suicide - prevention & control | Dextroamphetamine - adverse effects | Seizures - chemically induced | Heart Rate - drug effects | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Guanfacine - adverse effects | Atomoxetine Hydrochloride | Blood Pressure - drug effects | Child | Methylphenidate - administration & dosage | Substance-Related Disorders - etiology | Growth Disorders - chemically induced | Body Size - drug effects | Psychoses, Substance-Induced | Sleep Wake Disorders - therapy | Clonidine - adverse effects | Treatment Outcome | Methylphenidate - adverse effects | Seizures - therapy | Substance-Related Disorders - therapy | Attention Deficit Disorder with Hyperactivity - drug therapy | Propylamines - administration & dosage | Adolescent | Tic Disorders - chemically induced | Cardiovascular Diseases - chemically induced | Propylamines - adverse effects | Side effects | Drug therapy | Children & youth | Best practice
Journal Article
Journal Article